Although the 50 μg GFAP mAb group also exhibited a downward trend in the expression of these proteins, the changes did not reach statistical significance compared to the vehicle.
← all excerpts
Targeting glial fibrillary acidic protein in glaucoma: a monoclonal antibody approach to modulate glial reactivity and neuroinflammation for neuroprotection.
1
—
—